Opioid Use Disorder
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
23 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 45 trials with date data
Clinical Trials (45)
Total enrollment: 20,859 patients across 45 trials
Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic
Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations
Novel Induction to Buprenorphine/Naloxone
Virginia Opioid Treatment-Emergency Department
Virginia Opioid Overdose Treatment InitiatVE
Open-Label Treatment Extension Study
Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
A Study of Brenipatide in Participants With Opioid Use Disorder
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder
Reducing Pain and Opioid Use With CBD
A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
Phase II Pharmacokinetics Study of CAM2038
Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder
Sublingual Dexmedetomidine for Treating Opioid Withdrawal
iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers
A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine
Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).
Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants
A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.
Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants
A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder
Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
Single Ascending Dose Study of RBP-6000
Single-dose, Study of RBP-6000 in Opioid Dependent Individuals
Reentry Incentives and Support for Engagement With Contingency Management
PRoducing Outcome Measures for OTP Quality Improvement
AvertD Post-Approval Study
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD
Evaluating the SUBLOCADE Treatment Exit Strategy
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD)
SUBLOCADE Long-term Outcomes
Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms
A Multi-site Intervention to Expand Hospital Based OUD Treatment Provision
Neuroplasticity in Maternal Opioid Use Disorder (OUD)
Remotely Observed Methadone Evaluation
Effects of RME on Engagement in Buprenorphine Treatment
Patient Decision Aid for Opioid Use Disorder
Pilot Test of Patient Decision Aid for Opioid Use Disorder
MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)
Related Jobs
Rotational Key Account Manager, Harrisburg, PA
Regional Business Specialist, NJ / NYC / LI
Key Account Manager, Torrance, CA
Key Account Manager, Wilmington, DE
Key Account Manager, Central Jersey
Regional Business Specialist, MT / MN / ND
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.